U.S., June 10 -- ClinicalTrials.gov registry received information related to the study (NCT07636499) titled 'Application of Endoscopic Selective Neck Dissection Under Multimodal Assessment for Residual Cervical Lymph Nodes in N3 Nasopharyngeal Carcinoma After Radiotherapy' on May 26.

Brief Summary: The goal of this phase I clinical trial is to learn whether a multimodal follow-up evaluation combined with endoscopic selective neck dissection (ESND) is safe and feasible in patients with newly diagnosed N3 nasopharyngeal carcinoma.

The main questions it aims to answer are:

* Is the multimodal evaluation-guided surveillance-intervention approach safe for patients?

* Is this approach feasible for identifying and managing residual cervical ly...